Dr Roland on a Study of Neoadjuvant Immune-Checkpoint Blockade Across Sarcoma Subtypes
Christina L. Roland, MD, MS, FACS, discusses a study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma.
United States Christinal Roland University Of Texas Md Anderson Cancer Center Sarcoma Center Md Anderson Cancer Network Department Of Surgical Oncology
Source: onclive.com